A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Clinical trial NCT06782490 · RECRUITING

Trial details

NCT number: NCT06782490
Sponsor: Celgene
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis Spasticity

Start date: 2025-06-05
Primary completion: 2027-05-26
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.